Board changes

Well, one or several of the major shareholders have flexed their muscle and appointed 2 new Board members and asked Mr. Fox to resign. They are both biotech execs and board members and although they appear to be bona fide, increasing the size of this particular company's Board is nuts. The two new members don't give control, as the current members and executive members were all selected by Mr. Plumb.

Incidentally, Mr. Plumb sold a parcel of shares just before these changes were announced. And, he managed to sell them for 40 cents above the market price -lucky guy.

The lack of news on LANI becomes more noticeable. How it is possible to let this compound slip away is just beyond comprehension. Another northen hemisphere winter trial season passes, another year less patent life.

So, they pay 17 million for a antiviral gel Phase 1 tested on a couple of dozen patients in a deal done in a matter of months, while a compound like LANI has sat for over a year.

FY result press release: guess what word doesn't appear in the release

if you said INAVIR - correct!

Not once.

Inavir has been disappeared.